Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Angaran

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Journal of the American Heart Association|December 31, 2020
Differences in Healthcare Use Between Patients With Persistent and Paroxysmal Atrial Fibrillation Undergoing Catheter-Based Atrial Fibrillation Ablation: A Population-Based Cohort Study From Ontario, CanadaAndrew C T Ha, Harindra C Wijeysundera, Feng Qiu, et al.
European Heart Journal|May 19, 2021
Short-coupled ventricular fibrillation represents a distinct phenotype among latent causes of unexplained cardiac arrest: a report from the CASPER registryChristian Steinberg, Brianna Davies, Greg Mellor, et al.
American Heart Journal|February 27, 2022
Augmented wide area circumferential catheter ablation for reduction of atrial fibrillation recurrence (AWARE) trial: Design and rationaleGirish M Nair, David H Birnie, George A Wells, et al.
Circulation. Arrhythmia and Electrophysiology|September 17, 2016
Cardiac Abnormalities in First-Degree Relatives of Unexplained Cardiac Arrest Victims: A Report From the Cardiac Arrest Survivors With Preserved Ejection Fraction RegistryChristian Steinberg, Gareth J Padfield, Jean Champagne, et al.
The New England Journal of Medicine|November 16, 2020
Cryoablation or Drug Therapy for Initial Treatment of Atrial FibrillationJason G Andrade, George A Wells, Marc W Deyell, et al.
The American Journal of Cardiology|March 3, 2015
Risk stratification and stroke prevention therapy care gaps in Canadian atrial fibrillation patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation chart audit)Ashish D Patel, Mary K Tan, Paul Angaran, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|June 23, 2022
Randomized trial of conventional versus radiofrequency needle transseptal puncture for cryoballoon ablation: the CRYO-LATS trialJason G Andrade, Laurent Macle, Matthew T Bennett, et al.
Circulation. Cardiovascular Genetics|June 11, 2017
Genetic Testing in the Evaluation of Unexplained Cardiac Arrest: From the CASPER (Cardiac Arrest Survivors With Preserved Ejection Fraction Registry)Greg Mellor, Zachary W M Laksman, Rafik Tadros, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 18, 2025
Long-term all-cause mortality and hospitalizations after catheter ablation in patients with paroxysmal and persistent atrial fibrillationChristopher C Cheung, Feng Qiu, Olivia Haldenby, et al.
American Heart Journal|August 28, 2022
Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationalePablo B Nery, George A Wells, Atul Verma, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Journal of the American Heart Association|December 31, 2020
Differences in Healthcare Use Between Patients With Persistent and Paroxysmal Atrial Fibrillation Undergoing Catheter-Based Atrial Fibrillation Ablation: A Population-Based Cohort Study From Ontario, CanadaAndrew C T Ha, Harindra C Wijeysundera, Feng Qiu, et al.
European Heart Journal|May 19, 2021
Short-coupled ventricular fibrillation represents a distinct phenotype among latent causes of unexplained cardiac arrest: a report from the CASPER registryChristian Steinberg, Brianna Davies, Greg Mellor, et al.
American Heart Journal|February 27, 2022
Augmented wide area circumferential catheter ablation for reduction of atrial fibrillation recurrence (AWARE) trial: Design and rationaleGirish M Nair, David H Birnie, George A Wells, et al.
Circulation. Arrhythmia and Electrophysiology|September 17, 2016
Cardiac Abnormalities in First-Degree Relatives of Unexplained Cardiac Arrest Victims: A Report From the Cardiac Arrest Survivors With Preserved Ejection Fraction RegistryChristian Steinberg, Gareth J Padfield, Jean Champagne, et al.
The New England Journal of Medicine|November 16, 2020
Cryoablation or Drug Therapy for Initial Treatment of Atrial FibrillationJason G Andrade, George A Wells, Marc W Deyell, et al.
The American Journal of Cardiology|March 3, 2015
Risk stratification and stroke prevention therapy care gaps in Canadian atrial fibrillation patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation chart audit)Ashish D Patel, Mary K Tan, Paul Angaran, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|June 23, 2022
Randomized trial of conventional versus radiofrequency needle transseptal puncture for cryoballoon ablation: the CRYO-LATS trialJason G Andrade, Laurent Macle, Matthew T Bennett, et al.
Circulation. Cardiovascular Genetics|June 11, 2017
Genetic Testing in the Evaluation of Unexplained Cardiac Arrest: From the CASPER (Cardiac Arrest Survivors With Preserved Ejection Fraction Registry)Greg Mellor, Zachary W M Laksman, Rafik Tadros, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 18, 2025
Long-term all-cause mortality and hospitalizations after catheter ablation in patients with paroxysmal and persistent atrial fibrillationChristopher C Cheung, Feng Qiu, Olivia Haldenby, et al.
American Heart Journal|August 28, 2022
Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationalePablo B Nery, George A Wells, Atul Verma, et al.
Pageof 8